Related Experiment Video
Updated: Apr 18, 2026

09:54
Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models
Published on: December 3, 2019
10.9K
Study of viral pathogenesis in humanized mice.
Jenna M Gaska1, Alexander Ploss1
1Department of Molecular Biology, Princeton University, 110 Lewis Thomas Laboratory, Washington Road, Princeton, NJ 08544-1014, USA.
Current Opinion in Virology
|January 26, 2015
Summary
Humanized mouse models are crucial for studying viral infections and developing therapies. These models improve our understanding of host responses and aid in testing treatments for diseases like HIV and MERS-CoV.
Area of Science:
- Virology
- Immunology
- Infectious Diseases
Background:
- Many human viral pathogens exhibit restricted species tropism, complicating pathogenesis research and therapeutic development.
- Humanized mouse models have advanced significantly over the last 30 years.
- These models offer a cost-effective and ethical platform for studying host-pathogen interactions.
Purpose of the Study:
- To highlight the utility of humanized mouse models in infectious disease research.
- To demonstrate their role in understanding viral pathogenesis and host immune responses.
- To showcase their application in preclinical therapy testing.
Main Methods:
- Utilizing humanized mouse models to study a range of viral infections.
- Analyzing host immune responses within these models.
- Evaluating the efficacy of candidate therapies in preclinical settings.
Main Results:
- Humanized mice have been instrumental in identifying key factors in viral life cycles.
- These models facilitate the testing of novel antiviral therapies.
- They enhance the analysis of human immune responses to infections like HIV, hepatitis viruses, and MERS-CoV.
Conclusions:
- Humanized mouse models are indispensable tools for advancing infectious disease research.
- They provide critical insights into viral pathogenesis and host immunity.
- Their continued use is vital for addressing emerging and existing viral threats.

